Clin2
NCT06914180Possibly a fitNot yet recruiting

Esketamine plus nerve procedure for facial shingles pain

Postherpetic; Neuralgia, Trigeminal (Etiology)

Treatments studied

Part of Brain & nervous system, Pain clinical trials.

This trial tests whether adding a medication called esketamine to a standard nerve procedure (pulse radiofrequency) can better reduce facial pain from shingles. Esketamine may help block pain signals more effectively.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
174 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must be 18 or older.
  • Your pain must have lasted more than 3 months after the shingles rash started.
  • The pain must be on your face (in one of the trigeminal nerve areas).
  • Your average pain score must be at least 4 out of 10.
  • You must be scheduled for a CT-guided pulse radiofrequency (PRF) treatment—a procedure that uses short pulses of energy to reduce pain in the nerve.
  • You cannot have certain health conditions, such as sleep apnea, severe heart/lung/liver/kidney problems, immune diseases, cancer, or be pregnant.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06890897Recruiting
Esketamine with pulsed radiofrequency for shingles-related face pain

This trial tests whether adding esketamine (a medicine related to ketamine) to a standard nerve treatment (pulsed radiofrequency) can better relieve face pain caused by shingles. It may help if you have ongoing, moderate-to-severe pain in your face or scalp.

Beijing
NCT06914193Not yet recruiting
Esketamine plus nerve block for shingles-related pain

This study tests a combination of two treatments for long-term nerve pain after shingles: a medication called esketamine and a nerve block (pulsed radiofrequency) applied to the affected spinal nerves. The goal is to see if this combination relieves the burning or shooting pain better than the nerve block alone.

Beijing, Beijing Municipality
NCT06914206Not yet recruiting
Esketamine added to nerve block for recent shingles pain

This study tests whether adding a medicine called esketamine to a standard nerve block procedure can improve pain relief for people with shingles-related nerve pain. If you have had shingles pain for less than 3 months, this might help reduce pain and prevent long-term discomfort.

Beijing, Beijing Municipality
NCT06896994Recruiting
Study of esketamine plus pregabalin and duloxetine for shingles nerve pain

This trial tests whether adding esketamine to two standard pain medicines (pregabalin and duloxetine) can better treat nerve pain from shingles that persists for months. It's for people whose pain hasn't improved enough with pregabalin alone.

Beijing, Beijing Municipality
NCT07361796Recruiting
Venlafaxine to prevent nerve pain after shingles

This trial tests whether the drug venlafaxine, usually used for depression, can help prevent long-term nerve pain (postherpetic neuralgia) after a shingles infection. If you are currently experiencing shingles pain, joining this study might reduce your chances of developing chronic pain later.

Beijing
NCT06261801Recruiting
Acupuncture plus pregabalin for shingles pain on the face

This trial tests whether adding acupuncture (electroacupuncture) to the standard pain medicine pregabalin can better relieve facial shingles pain that started 1 to 3 months ago. It's for people with moderate pain who are willing to try both treatments together.

Hangzhou, Zhejiang

Hear when a new Postherpetic; Neuralgia, Trigeminal (Etiology) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.